Zenlabs Ethica Limited

ZENLABS6

INE546F01013

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:00:42 2024-05-18 am EDT			5-day change	1st Jan Change
44.7 ^INR	+1.61%		-0.67%	+7.97%

Jan. 29	Zenlabs Ethica Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
2023	Zenlabs Ethica Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	CI

Zenlabs Ethica Limited Appoints Divya Gupta as the Company Secretary and Compliance Officer

July 10, 2021 at 05:29 am EDT

Zenlabs Ethica Limited announced the appointment of Divya Gupta as the company secretary and compliance officer of the company with effect rom July 10, 2021.

Latest news about Zenlabs Ethica Limited

Zenlabs Ethica Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 29	CI
Zenlabs Ethica Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 06	CI
Zenlabs Ethica Limited Announces Resignation of Ashok Gupta as Independent Director of the Company with Immediate Effect from the Close of Business Hours of 18Th October 2023	23-10-19	CI
Hitesh Popatlal Oswal Leaves His Position of Additional Director from Additional Director	23-09-30	CI
Zenlabs Ethica Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-31	CI
Zenlabs Ethica Appoints CFO	23-07-30	MT
Zenlabs Ethica Limited Announces Executive Changes	23-07-28	CI
Zenlabs Ethica Limited Appoints Askhay Saxena as Company Secretary Cum Compliance Officer	23-07-28	CI
Zenlabs Ethica Limited Announces CFO Changes	23-07-28	CI
Zenlabs Ethica Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-24	CI
Zenlabs Ethica Limited Announces Resignation of Tanvi Chhabra from the Post of Company Secretary & Compliance Officer	23-05-01	CI
Zenlabs Ethica Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-09	CI
Zenlabs Ethica Limited Appoints Hitesh Popatlal Oswal as the Additional Director	22-11-21	CI
Zenlabs Ethica Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-10-18	CI
Zenlabs Ethica Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-07-20	CI
Zenlabs Ethica Limited Declares Interim Dividend, Payable on or Before August 18, 2022	22-07-20	CI
Zenlabs Ethica Limited Announces Appointment of Tanvi Chhabra as Company Secretary and Compliance Officer	22-06-30	CI
Zenlabs Ethica Limited Announces Resignation of Divya Gupta as Company Secretary and Compliance Officer	22-06-03	CI
Zenlabs Ethica Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-14	CI
Zenlabs Ethica Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-10-30	CI
Zenlabs Ethica Limited Announces Resignation of Chander Sheel Baweja from the Position of the Independent Director	21-09-03	CI
Zenlabs Ethica Limited Announces Resignation of Directors	21-09-03	CI
Zenlabs Ethica Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	21-07-22	CI
Zenlabs Ethica Limited Appoints Divya Gupta as the Company Secretary and Compliance Officer	21-07-10	CI
Zenlabs Ethica Limited Announces Resignation of Ginny Uppal, with Effect from 30 June 2021	21-07-01	CI

Zenlabs Ethica Limited is an India-based marketing company. The Company is engaged in trading in a range of branded drugs, including gastrointestinal tract disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps and anti-bacterial drugs, nutraceuticals, and other. It has approximately five manufacturing units. It operates through three divisions: Zenlabs, Coles Pharma and Mega Star. Zenlabs division provides various products, including Analgesics & Anti-Inflammatory, Skin Preparations, Neurological Disorders, Eye, Ear and Nasal Drops, Anti-Diabetic, Anti-Depressant, Anti-Infective, Anti-Emetic, Steroid & Anabolic Steroid, Anti-Hypertensive Drugs, Anti Allergic, Anti Cold & Cough Syrup, Nutraceuticals, Antacid, Enzymes & Appetite Stimulant, Ayurvedic Preparation, GIT Disorders, Soap, and Other Pharmaceutical Drugs. Coles Pharma division provides various products, including Analgesics & Anti-Inflammatory, Nutraceuticals, Skin Preparations, and other.

Sector

Pharmaceuticals

Calendar

2024-05-19 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
ZENLABS ETHICA LIMITED	+7.97%	3.44M
MCKESSON CORPORATION	+21.93%	73.38B
CARDINAL HEALTH, INC.	-1.71%	24.13B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+10.34%	8.59B
HUADONG MEDICINE CO., LTD	-19.80%	8.06B
H. LUNDBECK A/S	+14.16%	5.26B
EBOS GROUP LIMITED	-0.03%	4.21B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+12.70%	4.17B
GALENICA AG	-2.54%	3.89B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+24.00%	3.71B

Pharmaceuticals Wholesale